2020
DOI: 10.1016/j.ijbiomac.2020.07.186
|View full text |Cite
|
Sign up to set email alerts
|

Comparative study on glucomannans with different structural characteristics: Functional properties and intestinal production of short chain fatty acids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 17 publications
(9 citation statements)
references
References 51 publications
0
9
0
Order By: Relevance
“…Likewise, the combination of D. officinale and other Chinese herbal medicine, such as Acanthopanax senticosus, Panaxnotoginseng, Didymocarpus hancei and Valeriana officinalis can also alleviate gastric mucosal injury (Guo, 2020b). The 14-days treatment of D. officinale glucomannans at 0.16 g/kg produced more SCFAs (mainly acetate and butyrate) in cecum and colon (Shi et al, 2020). It should be noted that polysaccharides LDOP-1 isolated from D. officinale could protect ethanol-induced gastric mucosal injury in vitro (250, 125, and 62.5 mg/ml for 2 h) and in vivo (100 and a very high dose of 400 mg/kg for 30 days) by regulating AMP-activated protein kinase (AMPK)/mTOR signaling pathway demonstrated by the increased levels of p-AMPK, light chain 3β (LC-3β), heme oxygenase-1 (HO-1) and Beclin-1, the decreased levels of p-mTOR and p62, and the reversed levels of caspase3, Bax, and Bcl-2 detected both in vitro and in vivo (Ke et al, 2020).…”
Section: Gastrointestinal Protective Effectmentioning
confidence: 96%
“…Likewise, the combination of D. officinale and other Chinese herbal medicine, such as Acanthopanax senticosus, Panaxnotoginseng, Didymocarpus hancei and Valeriana officinalis can also alleviate gastric mucosal injury (Guo, 2020b). The 14-days treatment of D. officinale glucomannans at 0.16 g/kg produced more SCFAs (mainly acetate and butyrate) in cecum and colon (Shi et al, 2020). It should be noted that polysaccharides LDOP-1 isolated from D. officinale could protect ethanol-induced gastric mucosal injury in vitro (250, 125, and 62.5 mg/ml for 2 h) and in vivo (100 and a very high dose of 400 mg/kg for 30 days) by regulating AMP-activated protein kinase (AMPK)/mTOR signaling pathway demonstrated by the increased levels of p-AMPK, light chain 3β (LC-3β), heme oxygenase-1 (HO-1) and Beclin-1, the decreased levels of p-mTOR and p62, and the reversed levels of caspase3, Bax, and Bcl-2 detected both in vitro and in vivo (Ke et al, 2020).…”
Section: Gastrointestinal Protective Effectmentioning
confidence: 96%
“…to create these feelings of satiety, including fenugreek galactomannan (Mathern, Raatz, Thomas, & Slavin, 2009), fructooligosaccharide (Cani et al, 2009), konjac, and of course acemannan (Shi et al, 2020).…”
Section: Digestion and Diabetes: Acemannan As A Soluble Dietary Fibrementioning
confidence: 99%
“…The type of oligosaccharide and the microbial community of the host influences the flux and load of short-chain fatty acids (Shi et al, 2020), but the major product is acetic acid, followed by glucose and cholesterol control (Alexander, Swanson, Fahey, & Garleb, 2019). Most of these effects are not restricted to acemannan; they are known to be outcomes from ingestion and digestion of nonstarch polysaccharides (soluble fibres) in general.…”
Section: Digestion and Diabetes: Acemannan As A Soluble Dietary Fibrementioning
confidence: 99%
See 2 more Smart Citations